+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Bariatric Surgery Market 2019-2025

  • ID: 4896981
  • Report
  • December 2019
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Allergan PLC
  • Aspire Bariatrics, Inc.
  • Gelesis, Inc.
  • Medtronic PLC
  • Olympus Corp.
  • Stryker Corp.
  • MORE
Global Bariatric Surgery Market Size, Share & Trends Analysis Report by Procedures (Biliopancreatic Diversion with a Duodenal Switch (bpd-ds), Adjustable Gastric Band Surgery, Sleeve Gastrectomy Surgery, and Gastric Bypass Surgery), by Devices (Gastric Bands, Gastric Balloons, Gastric Stapling Device, and Others), and by End-User (Hospitals and Clinics, and Ambulatory Surgical Centers) and Forecast 2019-2025.

The global bariatric surgery market is anticipated to grow at the CAGR of 5.2% during the forecast period. This is owing to rising prevalence of obesity and technological advancements in healthcare sector. Bariatric surgeries and its devices are used for weight loss by decreasing the swelling volume of stomach to systematized food with the process of digestive restriction and malabsorption. These surgeries process are performed by use of negligible invasive method and techniques. Increasing capital expenditure on healthcare and patient preference for minimally invasive surgeries are also driving the market growth across the globe. Furthermore, increasing government funding to improve healthcare facilities is also expected to boost market growth. However, high costs associated with surgery and post-surgery complications may impede the growth of the market.

Geographically, the global bariatric surgery market is classified into North America, Europe, Asia-Pacific, and Rest of the World. North America contributes a significant share in the global bariatric surgery market, followed by Europe. This is due to the presence of highest incidences and prevalence rate of obesity, significant investment in healthcare R&D, highest healthcare spending and so forth. Obesity has been considered to be an epidemic in the US that is responsible for high prevalence of other diseases including diabetes and heart diseases. However, Asia-Pacific is expected to be the fastest growing market owing to increasing healthcare expenditures and increasing medical tourism.

The global bariatric surgery market is influenced by product development and advancements conducted by the market players. The key players of the bariatric surgery market include Allergan, Inc., Cousin-Biotech, Medtronic PLC, Johnson & Johnson Services, Inc., Olympus Corp., ReShape Lifesciences, Inc. These players are playing a significant role in the growth of the bariatric surgery market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, and technological development, among others.

Research Methodology

The market study of the global bariatric surgery market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report is intended for bariatric surgery device manufacturers, investing companies, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Bariatric Surgery Market Research and Analysis by Procedures
2. Global Bariatric Surgery Market Research and Analysis by Devices
3. Global Bariatric Surgery Market Research and Analysis by End-User
The Report Covers
  • Comprehensive research methodology of the global bariatric surgery market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global bariatric surgery market.
  • Insights about market determinants which are stimulating the global bariatric surgery market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan PLC
  • Aspire Bariatrics, Inc.
  • Gelesis, Inc.
  • Medtronic PLC
  • Olympus Corp.
  • Stryker Corp.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Johnson & Johnson Services, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Olympus Corp.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Cousin-Biotech
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Medtronic PLC
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. ReShape Lifesciences, Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Bariatric Surgery Market by Procedures
5.1.1. Biliopancreatic Diversion with a Duodenal Switch (bpd-ds)
5.1.2. Adjustable Gastric Band Surgery
5.1.3. Sleeve Gastrectomy Surgery
5.1.4. Gastric Bypass Surgery
5.2. Global Bariatric Surgery Market by Devices
5.2.1. Gastric Bands
5.2.2. Gastric Balloons
5.2.3. Gastric Stapling Device
5.2.4. Others (Adjustable Gastric Bands and Bariatric Bed)
5.3. Global Bariatric Surgery Market by End-User
5.3.1. Hospitals and Clinics
5.3.2. Ambulatory Surgical Centers

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Allergan PLC
7.2. Apollo Endosurgery Inc.
7.3. Aspire Bariatrics, Inc.
7.4. Cousin-Biotech
7.5. EndoGastric Solutions, Inc.
7.6. Gelesis, Inc.
7.7. GI Dynamics, Inc.
7.8. Johnson & Johnson Services, Inc.
7.9. Mediflex Surgical Products
7.10. Medtronic PLC
7.11. Obalon Therapeutics, Inc.
7.12. Olympus Corp.
7.13. ReShape Lifesciences, Inc.
7.14. Sklar Surgical Instruments
7.15. Spatz3
7.16. Stryker Corp.
7.17. TransEnterix Surgical, Inc.
7.18. USGI Medical, Inc.
7.19. W. L. Gore & Associates, Inc.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan PLC
  • Apollo Endosurgery Inc.
  • Aspire Bariatrics, Inc.
  • Cousin-Biotech
  • EndoGastric Solutions, Inc.
  • Gelesis, Inc.
  • GI Dynamics, Inc.
  • Johnson & Johnson Services, Inc.
  • Mediflex Surgical Products
  • Medtronic PLC
  • Obalon Therapeutics, Inc.
  • Olympus Corp.
  • ReShape Lifesciences, Inc.
  • Sklar Surgical Instruments
  • Spatz3
  • Stryker Corp.
  • TransEnterix Surgical, Inc.
  • USGI Medical, Inc.
  • W. L. Gore & Associates, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll